Exploratory Basic Research in Glomerular Disease (R21)
The summary for the Exploratory Basic Research in Glomerular Disease (R21) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Exploratory Basic Research in Glomerular Disease (R21): The Division of Kidney, Urologic and Hematologic Diseases (DKUHD) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), invites applications from new or established investigators to pursue basic exploratory investigations of Glomerular Disease, which would foster development of new ideas enhancing the understanding of disease pathogenesis.
Federal Grant Title: | Exploratory Basic Research in Glomerular Disease (R21) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PA-06-228 |
Type of Funding: | Grant |
CFDA Numbers: | 93.849 |
CFDA Descriptions: | Kidney Diseases, Urology and Hematology Research |
Current Application Deadline: | No deadline provided |
Original Application Deadline: | Multiple Receipt Dates - See Link to Full Announce |
Posted Date: | Mar 09, 2006 |
Creation Date: | Nov 09, 2006 |
Archive Date: | Dec 15, 2006 |
Total Program Funding: | |
Maximum Federal Grant Award: | $200,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts County governments Public and State controlled institutions of higher education State governments Private institutions of higher education City or township governments Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Small businesses For profit organizations other than small businesses Native American tribal governments (Federally recognized)
- Additional Information on Eligibility
- Foreign institutions are eligible to apply. Eligible agencies of the Federal Government are eligible to apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
[email protected] [email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • Investigations on Primary Immunodeficiency Diseases (R01)
- • Grants for Basic Research in Glomerular Diseases (R01)
- • Advances in Polycystic Kidney Disease (R01)
- • Ancillary Studies of Kidney Disease Accessing Information from Clinical Trials, Epidemiolo...
- • Calcium Oxalate Stone Diseases (R01)
- • Research Grants for Clinical Studies of Kidney Diseases
- • Chronic Prostatitis Collaborative Research Network (Cpcrn)
- • Frequent Hemodialysis Clinical Trials
- More Grants from the National Institutes of Health
- • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
- • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...
- • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...
- • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
- • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...